Welcome!

API Journal Authors: PagerDuty Blog, Liz McMillan, Igor Drobiazko, Elizabeth White, Kevin Benedict

News Feed Item

Global Proteomics Industry

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Proteomics Industry

http://www.reportlinker.com/p092466/Global-Proteomics-Industry.html#utm_...

 

This report analyzes the worldwide markets for Proteomics in US$ Million by the following Product Segments: Expression Proteomics, Functional Proteomics, and Structural Proteomics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period of 2010 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 111 companies including many key and niche players such as ActivX Biosciences, Inc., Adnexus Therapeutics, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Daltonics, Inc., Caprion Proteomics, Inc., Digilab Genomic Solutions, Inc., Dionex Corporation, GE Healthcare, Geneva Bioinformatics S.A., Hybrigenics SA, Life Technologies Corporation, Millipore Corp., PerkinElmer, Inc., Caliper Life Sciences, Shimadzu Biotech, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Waters Corp., Xencor Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

 

 

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Expression Proteomics I-3

Functional Proteomics I-3

Structural Proteomics I-4

 

 

II. EXECUTIVE SUMMARY

 

1. GLOBAL MARKET OVERVIEW II-1

Proteomics - The Current Spotlight II-1

Market Drivers II-1

Transition from Genomics to Proteomics II-1

Industrialization of Proteomics Research II-2

International Initiatives Light-up Proteomics Market II-2

Factors Limiting Market Growth II-2

Economic Recession Impact on the Life Sciences Industry in

Retrospect II-2

Biotechnology Sector - Affected by Collapse of Capital Market II-3

Tough Times for Market Participants II-3

Proteomics Technologies: Growing in Significance II-4

Transformation of Drug Discovery through Proteomics and Genomics II-5

Proteomics: A Critical Drug Discovery Tool II-5

China All Set To Play a Major Role in the Proteomics Industry II-6

Global Proteomics Sample Preparation Market - On a Growth Curve II-7

Challenges Facing Proteomics Sample Preparation Market II-7

Challenges Facing Proteomics Industry II-7

Protein Chemistry and its Complexities II-7

Integration of Data & Equipment II-7

Data Validation - A Burning Issue II-8

Standardization & Consistency - A Prime Concern II-8

Incomplete and Disorganized Data II-8

 

2. INDUSTRY COMPETITION II-9

Industry Participants II-9

Proteomics Market Worldwide: Competitive Landscape II-9

Proteomics Supplier Market II-9

Tool Providers: Leading the Proteomics Market II-10

Applied Biosystems-Invitrogenc Corporation Merger - A Key

Development II-10

Challenges Ahead II-11

Designing a Novel Business Model II-11

Role of Contract Research Organizations - All Set to Increase

in Proteomics II-11

 

3. PRODUCT AND TECHNOLOGY OVERVIEW II-12

Proteins, Proteome and Proteomics!!! - What are They? II-12

Proteomics - An Introduction II-12

Genesis of Proteomics II-13

Tales From Times Gone By II-13

Components of Proteomics II-13

Expression Proteomics II-13

Functional Proteomics II-14

Cell-map Proteomics II-14

Structural Proteomics II-14

Technologies and Proteomics II-14

Proteomics and Genomics II-15

Proteomics and Genomics: A Comparison II-15

Protein Production Pathway: From Gene Expression to

Functional Protein with Controls II-15

From Genomics to Proteomics II-16

Functional Genomics and Proteomics II-16

Push From Genomic Information II-17

An Insight into Proteomics Data Type and their

Characteristics / Features II-17

Standard Proteomics Approach II-17

Sample Preparation - Step I II-18

Protein Separation - Step II II-18

Protein Visualization II-18

Protein Expression Analysis-Step III II-18

Protein Identification - Step IV II-19

Data Storage and Processing - Step V II-19

 

4. OVERVIEW OF PROTEOMICS TECHNOLOGIES II-20

A Snapshot of Various Proteomics Tools II-20

An Insight into Various Proteomics Technologies and their

Application Areas II-20

Protein Separation II-20

2-Dimensional Gel Electrophoresis (2DGE) II-20

Protein Characterization II-22

Analysis of Protein Through Mass Spectrometry II-22

MS and Proteins II-22

Applications of MS II-23

Problems Associated with MS II-24

Types of Analyzers or Filters II-24

Y2H, Yeast 2-Hybrid System II-25

Protein Microarrays II-26

Chip Technology II-26

Microfluidic Applications II-27

Role of Bioinformatics in Proteomics II-27

Bioinformatics Applications and Tools in Proteomics II-27

Emerging Proteomics Technologies II-29

MudPIT II-29

ICAT II-29

Phage Display Technique II-30

Advanced Proteomics Technologies: Structural Analysis Tools II-30

X-ray Crystallography II-30

Nuclear Magnetic Resonance (NMR) II-30

In silico Modelling II-31

Physicochemical Factors Constraining Metabolic Functions II-31

 

5. END-USE APPLICATION AREAS II-32

Proteomics in Drug and Diagnostic Discovery II-33

Proteomics and Drug Discovery II-33

Protein Microarrays: A New Tool for the Development of

Pharmaceuticals II-34

Proteomic Approaches Gain Prominence in Cancer Drug Discovery II-34

Advancements in Proteomics Bring Biomarkers into Limelight II-35

 

6. NEW PRODUCT SOLUTIONS/ DEVELOPMENTS II-36

Applied Biomics Introduces Global Protein Post- Translational

Modification II-36

AB SCIEX Launches New Column Chips II-36

Applied Biomics Introduces New Mass Spectrometry Service II-37

Norton Scientific Introduces Novel Specialist Applications

Development Laboratory Service II-37

Gentel Biosciences Introduces APiXTM Disease Profiling Kit II-38

Integromics Introduces OmicsHub Proteomics 2.0 II-38

Bruker Introduces amaZon Speed Ion Trap Mass Spectrometers II-39

Applied Biomics Introduces iTRAQ Service for Proteomics Research II-39

Norton Scientifc Company Introduces New Lab Support Service

for Rapid RNA/DNA and Protein Measurement II-39

Bruker Launches MALDI BiotargetTM II-40

Thermo Fisher Launches UHLPC System II-40

Kinexus Introduces Human Gene Online TranscriptoNET KnowledgeBase II-41

Bruker Launches PRIME Integrated Proteomics Solution II-42

Applied Biosystems Launches LS*LIMS Laboratory Automation

Technology for Proteomics and Genomics II-42

Kinexus Bioinformatics Introduces Online KiNET-AM Proteomics

DataBase II-42

Bruker Rolls Out CaptiveSpray Electrospray Ion Source for

Proteomics Applications II-43

Thermo Fisher Launches New Capabilities for Performing

Proteomics Workflows II-43

National Cancer Institute Introduces Clinical Proteomic Tumor

Analysis Consortium for Cancer Studies II-44

KinaSorbTM' - New Kit for Kinase Enrichment II-45

 

7. PRODUCT INTRODUCTIONS/INNOVATIONS IN RECENT PAST - A

PERSPECTIVE BUILDER II-46

Gentel Biosciences Unveils Gentel Proteomics Multi-SystemTM II-46

caprotec bioanalytics Introduces Innovative caproKits II-46

Gentel Biosciences Introduces SilverQuant® Simian Pathogen

Array for Health Monitoring of Laboratory Animals II-46

Gentel Biosciences Introduces SilverQuant® Human Tumor

Profiling Kits II-46

Gentel Biosciences Introduces SilverQuant® Disease Profiling Kit II-47

Gentel Biosciences Introduces SilverQuant® View Detection Kits II-47

Gentel Biosciences Launches Proteomics Multi-System II-47

New England Peptide Introduces NEPTune™ Range of Proteomics

Reagents II-48

Applied Biomics Introduces NanoLC-MS/MS Service II-48

Life Technologies Introduces Magic Sample Processor for

Epigenetics, Proteomics Sample Preparation II-49

Integromics Introduces SeqSolve™ NGS Bioinformatics Analysis

Software II-50

Thermo Fisher Scientific Unveils Software Suite for Enhanced

Workflows in Proteomics II-50

Proxeon Introduces EASY-nLC II System for Improved

Productivity in Proteomics (Denmark) II-51

Gentel Biosciences Launches Proteomics Multi-System II-51

Arrayit Discovers New Proteomic Biomarkers II-52

Kinexus Bioinformatics Launches Peptide Development Facility II-52

Bruker Daltonics Unveils ultrafleXtreme™ MALDI-TOF/TOF Mass

Spectrometer II-52

Agilent Technologies Rolls Out HPLC-Chip II-53

Applied Biosystems and MDS Introduce AB SCIEX TOF/TOF™ 5800

System II-53

Applied Biomics Extends Proteomics Service Offerings II-54

AnaSpec Introduces Keratin Antibodies II-54

caprotec bioanalytics Unveils cAMP caproKit and SAH caproKit II-54

Huzhou Sai'erdi Biopharmaceutical Introduces Proteomic

Fingerprint Technology Test Kit II-54

 

8. RECENT INDUSTRY ACTIVITY II-55

Life Technologies Enters into Partnership with Sino Biological II-55

Proteome Sciences Signs Agreement with CHDI Foundation II-55

Waters Corp. Inks Agreement with Nonlinear Dynamics II-56

BioFocus Enters into Alliance with Activiomics II-56

Great Point Partners Divests Caprion Proteomics II-56

Glaxo Smith Kline Takes Over Cellzome II-57

Emerald BioSystems Changes Name to Emerald Bio II-57

Bruker Unveils Novel Nano-Advance UHPLC System II-57

Evotec Takes Over Kinaxo Biotechnologies II-58

Kinaxo Biotechnologies and AstraZeneca Sign Agreement II-58

Gentel Biosciences Takes Over Eppendorf's SilverQuant Trademark II-58

Thermo Fisher Takes Over Fermentas International II-58

KINAXO to Collaborate with Takeda II-59

Dualsystems and Bulldog Bio Signs Exclusive Marketing Agreement II-59

Novartis Enters into Agreement with SomaLogic II-59

Sage-N Inks Exclusive Pact With the U.S. Army II-59

Proteome Sciences Inks Agreement with Moffitt Cancer Center II-60

Gentel Biosciences Enters into Agreement with Oregon Health &

Science University II-60

Evotec OAI Forms Joint Venture with MeITec to Collaborate on

Drug Discovery Services II-60

 

9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-61

MicroBioChips Merges with Biosystems II-61

Caprion Proteomics Acquires Biomarket Unit from PPD Biomarker

Discovery Sciences II-61

ICON Enters into Strategic Alliance with Proteome Sciences II-61

Gentel Enters into Partnership with RayBiotech for

SilverQuant® Chromogenic Detection Platform II-61

Trans-Hit Biomarkers Enters into Alliance with Caprion to

Deliver Proteome-Hit Services II-62

Proteoprep Enters into License Agreement with Sigma-Aldrich II-62

Activiomics Signs Technology Agreement with UCB for Proteomics

Platform(UK/Belgium) II-63

Expression Pathology Enters into Service Partnership with

Flagship for Tissue Proteomics Development II-63

National Cancer Institute Enters into MoU with AACC in

Proteomics Sector II-63

MGL Americas and ProFACT Proteomics Team Up for Biomarker

Discovery II-64

Thermo Fisher Scientific and Luxembourg Clinical Proteomics

Unit Form Collaboration (Luxembourg) II-64

Covance Unveils Discovery and Translational Services Division II-65

Thermo Fisher Scientific Takes Over Proxeon II-65

TriLink BioTechnologies and Nacalai USA Sign Distribution

Agreement II-65

Cell Biosciences Takes Over Alpha Innotech II-65

Eurogentec to Take Over Ana Spec II-66

Merck Takes Over Bangalore Genei II-66

Cell Biosciences Takes Over Protein Forest II-66

Microsoft to Acquire Rosetta Bio Software Assets II-67

CCMB and Bio-Rad India Sign MoU II-67

SAIC-Frederick and Sensor Technologies Ink Collaboration

Agreement II-67

NuSep Signs Purchase Agreement with BioInquire II-68

Intrinsic Bioprobes Bags Contract from NCI II-68

HORIBA Jobin Yvon Acquires GenOptics II-68

Gentel Biosciences Partners with Eprogen II-68

Bruker Daltonics Installs High-Field 15 Tesla and 12 Tesla

FTMS Systems at LUMC II-69

Genedata Extends Collaboration with Roche II-69

AliX Merges with Novalyst Discovery to form NovAliX II-70

BioPike and AnaSpec Sign Agreement II-70

Sigma-Aldrich Purchases Electrophoresis Business of NextGen

Sciences II-70

Fujifilm Purchases Additional Stake in Perseus Proteomics II-71

Sigma-Aldrich Buys Seppro® Depletion Technology and 700

Antibodies II-71

Oxford Gene Technology Purchases Sense Proteomic II-72

Center for Cancer Research Acquires Waters® UPLC/MS Systems II-72

 

10. FOCUS ON SELECT KEY PLAYERS II-74

ActivX Biosciences, Inc. (US) II-74

Adnexus Therapeutics (US) II-74

Agilent Technologies, Inc. (US) II-74

Bio-Rad Laboratories, Inc. II-74

Bruker Daltonics, Inc. (US) II-75

Caprion Proteomics, Inc. (Canada) II-75

Digilab Genomic Solutions, Inc. (US) II-76

Dionex Corporation (US) II-76

GE Healthcare (United Kingdom) II-76

Geneva Bioinformatics S.A. (Switzerland) II-76

Hybrigenics SA (France) II-76

Life Technologies Corporation (US) II-77

Millipore Corp. (US) II-77

PerkinElmer, Inc. (US) II-78

Caliper Life Sciences (US) II-78

Shimadzu Biotech (Japan) II-78

Sigma-Aldrich Corporation (US) II-78

Thermo Fisher Scientific (US) II-79

Waters Corp. (US) II-79

Xencor Inc. (US) II-80

Zyomyx, Inc. (US) II-80

 

11. GLOBAL MARKET PERSPECTIVE II-81

Table 1: World Recent Past, Current & Future Analysis for

Proteomics by Geographic Region - US, Canada, Japan, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-81

 

Table 2: World Historic Review for Proteomics by Geographic

Region - US, Canada, Japan, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-82

 

Table 3: World 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe and Rest of World Markets for Years

2004, 2011 and 2018 (includes corresponding Graph/Chart) II-83

 

Table 4: World Recent Past, Current & Future Analysis for

Proteomics by Segment - Expression Proteomics, Functional

Proteomics and Structural Proteomics Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2010 through 2018 (includes corresponding Graph/Chart) II-84

 

Table 5: World Historic Review for Proteomics by Segment -

Expression Proteomics, Functional Proteomics and Structural

Proteomics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-85

 

Table 6: World 15-Year Perspective for Proteomics by Segment -

Percentage Breakdown of Dollar Sales for Expression

Proteomics, Functional Proteomics and Structural Proteomics

Markets for Years 2004, 2011 and 2018 (includes corresponding

Graph/Chart) II-86

 

12. GLOSSARY OF TERMS II-87

1-D, 2-D, 3-D II-87

Atmospheric Pressure Ionisation II-87

Electrophoresis II-87

Functional Genomics II-87

High-Throughput II-87

Liquid Chromatography (LC) II-87

Mass Spectrometry (MS) II-87

Matrix-Assisted Laser Desorption Ionisation (MALDI) II-87

Nuclear Magnetic Resonance II-88

X-ray Diffraction II-88

Yeast Two-Hybrid System II-88

2D-PAGE (Two-dimensional PolyAcrylamide Gel Electrophoresis) II-88

TOF (Time of Flight) II-88

Quadrupole II-88

Q-TOF (Quadrupole Time of Flight) II-88

ESI (Electrospray Ionisation) II-88

 

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Outlook III-1

Proteomics Sample Preparation Market III-1

New Product Developments III-1

Strategic Corporate Developments III-6

Select Key Players III-9

B.Market Analytics III-14

Table 7: The US Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-14

 

Table 8: The US Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-15

 

2. CANADA III-16

A.Market Analysis III-16

Outlook III-16

New Product Developments III-16

Strategic Corporate Development III-18

Caprion Proteomics, Inc. - A Key Player III-18

B.Market Analytics III-19

Table 9: Canadian Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-19

 

Table 10: Canadian Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-20

 

3. JAPAN III-21

A.Market Analysis III-21

Shimadzu Biotech - A Key Player III-21

B.Market Analytics III-21

Table 11: Japanese Recent Past, Current & Future Analysis

for Proteomics Market Analyzed with Annual Sales Figures in

US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-21

 

Table 12: Japanese Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-22

 

4. EUROPE III-23

A.Market Analysis III-23

Outlook III-23

Proteomics Research in Europe - An Overview III-23

Table 13: European Proteomics Market (2011): Percentage

Breakdown of Deployment of Proteomics Technologies in

End-Use Segments - Research and Academic Institutions,

Pharmaceutical Companies and Clinical Laboratories

(includes corresponding Graph/Chart) III-24

Protein Identification Market III-24

Protein Separation Market III-24

Market Challenges III-25

Gaining Edge in the Proteomics Industry - Player Strategies III-25

European 2DE Market - Benefiting from Recession III-26

Review of Select Markets III-26

Germany III-26

The United Kingdom III-26

New Product Developments III-27

Strategic Corporate Developments III-28

Select Key Players III-30

B.Market Analytics III-31

Table 14: European Recent Past, Current & Future Analysis

for Proteomics by Geographic Region - France, Germany, UK

and Rest of Europe Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-31

 

Table 15: European Historic Review for Proteomics by

Geographic Region - France, Germany, UK and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-32

 

Table 16: European 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

France, Germany, UK andRest of Europe Markets for Years

2004, 2011 and 2018 (includes corresponding Graph/Chart) III-33

 

5. REST OF WORLD III-34

A.Market Analysis III-34

Outlook III-34

Australia III-34

India III-34

Indian Scientific Research towards Functional Genomics and

Proteomics III-34

B.Market Analytics III-35

Table 17: Rest of World Recent Past, Current & Future

Analysis for Proteomics Market Analyzed with Annual Sales

Figures in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-35

 

Table 18: Rest of World Historic Review for Proteomics

Market Analyzed with Annual Sales Figures in US$ Million for

Years 2004 through 2009 (includes corresponding Graph/Chart) III-36

 

 

IV. COMPETITIVE LANDSCAPE

 

Total Companies Profiled: 111 (including Divisions/Subsidiaries - 128)

 

The United States (82)

Canada (4)

Japan (3)

Europe (39)

- France (3)

- Germany (10)

- The United Kingdom (13)

- Spain (1)

- Rest of Europe (12)

 

 

 

To order this report:

Drug_Discovery_and_Development Industry: Global Proteomics Industry

 

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

 

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
The IoTs will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, will demonstrate how to move beyond today's coding paradigm and share the must-have mindsets for removing complexity from the development proc...
Artificial Intelligence has the potential to massively disrupt IoT. In his session at 18th Cloud Expo, AJ Abdallat, CEO of Beyond AI, will discuss what the five main drivers are in Artificial Intelligence that could shape the future of the Internet of Things. AJ Abdallat is CEO of Beyond AI. He has over 20 years of management experience in the fields of artificial intelligence, sensors, instruments, devices and software for telecommunications, life sciences, environmental monitoring, process...
In his session at @ThingsExpo, Chris Klein, CEO and Co-founder of Rachio, will discuss next generation communities that are using IoT to create more sustainable, intelligent communities. One example is Sterling Ranch, a 10,000 home development that – with the help of Siemens – will integrate IoT technology into the community to provide residents with energy and water savings as well as intelligent security. Everything from stop lights to sprinkler systems to building infrastructures will run ef...
We’ve worked with dozens of early adopters across numerous industries and will debunk common misperceptions, which starts with understanding that many of the connected products we’ll use over the next 5 years are already products, they’re just not yet connected. With an IoT product, time-in-market provides much more essential feedback than ever before. Innovation comes from what you do with the data that the connected product provides in order to enhance the customer experience and optimize busi...
Manufacturers are embracing the Industrial Internet the same way consumers are leveraging Fitbits – to improve overall health and wellness. Both can provide consistent measurement, visibility, and suggest performance improvements customized to help reach goals. Fitbit users can view real-time data and make adjustments to increase their activity. In his session at @ThingsExpo, Mark Bernardo Professional Services Leader, Americas, at GE Digital, will discuss how leveraging the Industrial Interne...
The increasing popularity of the Internet of Things necessitates that our physical and cognitive relationship with wearable technology will change rapidly in the near future. This advent means logging has become a thing of the past. Before, it was on us to track our own data, but now that data is automatically available. What does this mean for mHealth and the "connected" body? In her session at @ThingsExpo, Lisa Calkins, CEO and co-founder of Amadeus Consulting, will discuss the impact of wea...
Increasing IoT connectivity is forcing enterprises to find elegant solutions to organize and visualize all incoming data from these connected devices with re-configurable dashboard widgets to effectively allow rapid decision-making for everything from immediate actions in tactical situations to strategic analysis and reporting. In his session at 18th Cloud Expo, Shikhir Singh, Senior Developer Relations Manager at Sencha, will discuss how to create HTML5 dashboards that interact with IoT devic...
Whether your IoT service is connecting cars, homes, appliances, wearable, cameras or other devices, one question hangs in the balance – how do you actually make money from this service? The ability to turn your IoT service into profit requires the ability to create a monetization strategy that is flexible, scalable and working for you in real-time. It must be a transparent, smoothly implemented strategy that all stakeholders – from customers to the board – will be able to understand and comprehe...
A critical component of any IoT project is the back-end systems that capture data from remote IoT devices and structure it in a way to answer useful questions. Traditional data warehouse and analytical systems are mature technologies that can be used to handle large data sets, but they are not well suited to many IoT-scale products and the need for real-time insights. At Fuze, we have developed a backend platform as part of our mobility-oriented cloud service that uses Big Data-based approache...
trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing. In his session at @ThingsExpo, Lancen LaChance, vice president of product management, IoT solutions at GlobalSign, will teach IoT developers how t...
Digital payments using wearable devices such as smart watches, fitness trackers, and payment wristbands are an increasing area of focus for industry participants, and consumer acceptance from early trials and deployments has encouraged some of the biggest names in technology and banking to continue their push to drive growth in this nascent market. Wearable payment systems may utilize near field communication (NFC), radio frequency identification (RFID), or quick response (QR) codes and barcodes...
SYS-CON Events announced today that Peak 10, Inc., a national IT infrastructure and cloud services provider, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Peak 10 provides reliable, tailored data center and network services, cloud and managed services. Its solutions are designed to scale and adapt to customers’ changing business needs, enabling them to lower costs, improve performance and focus inter...
We're entering the post-smartphone era, where wearable gadgets from watches and fitness bands to glasses and health aids will power the next technological revolution. With mass adoption of wearable devices comes a new data ecosystem that must be protected. Wearables open new pathways that facilitate the tracking, sharing and storing of consumers’ personal health, location and daily activity data. Consumers have some idea of the data these devices capture, but most don’t realize how revealing and...
The demand for organizations to expand their infrastructure to multiple IT environments like the cloud, on-premise, mobile, bring your own device (BYOD) and the Internet of Things (IoT) continues to grow. As this hybrid infrastructure increases, the challenge to monitor the security of these systems increases in volume and complexity. In his session at 18th Cloud Expo, Stephen Coty, Chief Security Evangelist at Alert Logic, will show how properly configured and managed security architecture can...
The IETF draft standard for M2M certificates is a security solution specifically designed for the demanding needs of IoT/M2M applications. In his session at @ThingsExpo, Brian Romansky, VP of Strategic Technology at TrustPoint Innovation, will explain how M2M certificates can efficiently enable confidentiality, integrity, and authenticity on highly constrained devices.
There is an ever-growing explosion of new devices that are connected to the Internet using “cloud” solutions. This rapid growth is creating a massive new demand for efficient access to data. And it’s not just about connecting to that data anymore. This new demand is bringing new issues and challenges and it is important for companies to scale for the coming growth. And with that scaling comes the need for greater security, gathering and data analysis, storage, connectivity and, of course, the...
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, will provide tips on how to be successful in large scale machine lear...
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
SYS-CON Events announced today that Ericsson has been named “Gold Sponsor” of SYS-CON's @ThingsExpo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. Ericsson is a world leader in the rapidly changing environment of communications technology – providing equipment, software and services to enable transformation through mobility. Some 40 percent of global mobile traffic runs through networks we have supplied. More than 1 billion subscribers around the world re...
You deployed your app with the Bluemix PaaS and it's gaining some serious traction, so it's time to make some tweaks. Did you design your application in a way that it can scale in the cloud? Were you even thinking about the cloud when you built the app? If not, chances are your app is going to break. Check out this webcast to learn various techniques for designing applications that will scale successfully in Bluemix, for the confidence you need to take your apps to the next level and beyond.